Baird Upgrades MYR Group to Outperform, Raises Price Target to $95
Baird analyst Justin Hauke upgrades MYR Group (NASDAQ:MYRG) from Neutral to Outperform and raises the price target from $92 to $95.
Wells Fargo Upgrades Aeglea BioTherapeutics to Overweight, Raises Price Target to $2
Wells Fargo analyst Yanan Zhu upgrades Aeglea BioTherapeutics (NASDAQ:AGLE) from Equal-Weight to Overweight and raises the price target from $1.5 to $2.
Truist Securities Upgrades Gilead Sciences to Buy, Raises Price Target to $91
Truist Securities analyst Robyn Karnauskas upgrades Gilead Sciences (NASDAQ:GILD) from Hold to Buy and raises the price target from $76 to $91.
Piper Sandler Upgrades Unity Software to Overweight, Lowers Price Target to $38
Piper Sandler analyst Brent Bracelin upgrades Unity Software (NYSE:U) from Neutral to Overweight and lowers the price target from $42 to $38.
Keybanc Upgrades MYR Group to Overweight, Announces $99 Price Target
Keybanc analyst Sean Eastman upgrades MYR Group (NASDAQ:MYRG) from Sector Weight to Overweight and announces $99 price target.
CLSA Upgrades New Oriental Education to Buy
CLSA analyst Jeffrey Chan upgrades New Oriental Education (NYSE:EDU) from Outperform to Buy.
HSBC Upgrades Ferrari to Buy
HSBC analyst Henning Cosman upgrades Ferrari (NYSE:RACE) from Hold to Buy.
Cowen & Co. Upgrades Vertiv Holdings to Outperform, Raises Price Target to $20
Cowen & Co. analyst Lance Vitanza upgrades Vertiv Holdings (NYSE:VRT) from Market Perform to Outperform and raises the price target from $11.75 to $20.
Barclays Upgrades Annaly Capital Management to Overweight, Announces $19 Price Target
Barclays analyst Mark Devries upgrades Annaly Capital Management (NYSE:NLY) from Equal-Weight to Overweight and announces $19 price target.
Barclays Upgrades AGNC Investment to Overweight, Lowers Price Target to $9
Barclays analyst Mark Devries upgrades AGNC Investment (NASDAQ:AGNC) from Equal-Weight to Overweight and lowers the price target from $12 to $9.